4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-030300
EVP, Head of R&D sold 4,124 shares at $5.03 ($20,760)
From the SEC's structured data for this filing
Trades in this filing
Dupont Jakob · EVP, Head of R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-16 | Sale : show line 1 in the form | −4,124 | $5.03 | $20,760 | 158,882 | D |
| Open-market sales · 4,124 sh · avg $5.03 · $20,760 | ||||||
Loading xslF345X03/form4.xml…